文献速递妇科

早期子宫颈神经内分泌癌术后放疗的价值及预后因素分析

[Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2023-01-01

单中心回顾性队列纳入2011年1月至2022年4月北京协和医院62例早期NECC患者,术后放疗组盆腔内复发率有降低趋势(18% vs 3%,P=0.074)但差异无统计学意义,未降低盆腔外复发、总复发及死亡率;淋巴脉管间隙浸润为术后复发独立危险因素(OR=23.03)。

要点

  • 术后放疗有减少盆腔内复发趋势(18% vs 3%,P=0.074),但差异无统计学意义。
  • 术后放疗未降低盆腔外复发率(24% vs 41%,P=0.150)和总复发率(33% vs 41%,P=0.513)。
  • 淋巴脉管间隙浸润为术后复发独立危险因素(OR=23.03,95%CI 3.55~149.39,P=0.001)。

核心结论

  • 早期NECC术后放疗有减少盆腔内复发的趋势,但未能降低盆腔外复发率和总复发率,未能改善死亡率。
  • 子宫颈间质浸润≥1/2患者术后放疗有延长PFS和OS的趋势,但差异无统计学意义。
  • 淋巴脉管间隙浸润为术后复发独立危险因素,但此类患者术后放疗并无生存获益。

研究设计与样本

  • 单中心回顾性队列研究,纳入2011年1月至2022年4月北京协和医院收治的早期(Ⅰ~Ⅱa2期)NECC患者62例,均行子宫广泛性切除术±辅助治疗。
  • 按术后是否放疗分为术后未放疗组33例和术后放疗组29例。

主要发现

  • 中位随访37个月(范围12~116个月),23例(37%)复发,其中盆腔内复发7例(11%)、盆腔外复发20例(32%),4例(6%)盆腔内外均复发。
  • 术后放疗组盆腔内复发率18% vs 未放疗组3%(P=0.074),盆腔外复发率24% vs 41%(P=0.150),总复发率33% vs 41%(P=0.513),差异均无统计学意义。
  • 随访期内18例(29%,18/62)死亡,未放疗组10例(30%,10/33) vs 放疗组8例(28%,8/29),P=0.814。
  • 62例患者3年生存率79.2%,5年生存率60.8%。
  • 子宫颈间质浸润≥1/2在放疗组所占比例更高(27% vs 64%,P=0.011),此类患者术后放疗PFS 32.3 vs 53.9个月(P=0.704)、OS 39.4 vs 73.4个月(P=0.371),差异均无统计学意义。

关键数值与推荐

  • 单因素分析显示淋巴脉管间隙浸润、子宫颈间质浸润≥1/2均为术后复发危险因素(P均<0.05)。
  • 多因素分析显示淋巴脉管间隙浸润为术后复发独立危险因素(OR=23.03,95%CI 3.55~149.39,P=0.001)。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the effect of postoperative radiotherapy and high-risk pathological factors on the prognosis of early-stage neuroendocrine carcinoma of cervix (NECC). Methods: A single-center retrospective cohort study of early-stage NECC in Peking Union Medical College Hospital from January 2011 to April 2022 were enrolled. The patients were treated with radical hysterectomy±adjuvant treatment. They were divided into postoperative non-radiation group and postoperative radiation group. The possible postoperative recurrence risk factors identified by univariate analysis were assessed using multivariate logistic regression. The Kaplan-Meier method was used to analyze the progression free survival (PFS), overall survival (OS), recurrence rate, and mortality rate. Results: (1) Sixty-two cases were included in the study, including 33 cases in postoperative non-radiation group and 29 cases in postoperative radiation group. (2) The median follow-up time was 37 months (ranged 12-116 months), with 23 cases (37%) experienced recurrences. There were 7 cases (11%) pelvic recurrences and 20 cases (32%) distant recurrences, in which including 4 cases (6%) both pelvic and distant recurrences. Compared with postoperative non-radiation group, the postoperative radiation group had a lower pelvic recurrence rate (18% vs 3%; P=0.074) but without statistic difference, a slightly elevated distant recurrence rate (24% vs 41%; P=0.150) and overall recurrence rate (33% vs 41%; P=0.513) without statistically significances. Univariate analysis showed that lymph-vascular space invasion and the depth of cervical stromal invasion≥1/2 were risk factors for postoperative recurrence (all P<0.05). Multivariate analysis showed lymph-vascular space invasion was an independent predictor for postoperative recurrence (OR=23.03, 95%CI: 3.55-149.39, P=0.001). (3) During the follow-up period, 18 cases (29%, 18/62) died with tumor, with 10 cases (30%, 10/33) in postoperative non-radiation group and 8 cases (28%, 8/29) in postoperative radiation group, without significant difference (P=0.814). The postoperative 3-year and 5-year survival rate was 79.2%, 60.8%. The depth of cervical stromal invasion≥1/2 was more common in postoperative radiation group (27% vs 64%; P=0.011), and postoperative radiation in such patients showed an extended trend in PFS (32.3 vs 53.9 months) and OS (39.4 vs 73.4 months) but without statistic differences (P=0.704, P=0.371). Compared with postoperative non-radiation group, the postoperative radiation did not improve PFS (54.5 vs 37.3 months; P=0.860) and OS (56.2 vs 62.4 months; P=0.550) in patients with lymph-vascular space invasion. Conclusions: Postoperative radiation in early-stage NECC patients has a trend to reduce pelvic recurrence but not appear to decrease distant recurrence and overall recurrence, and has not improved mortality. For patients with the depth of cervical stromal invasion≥1/2, postoperative radiation has a trend of prolonging OS and PFS but without statistic difference. Lymph-vascular space invasion is an independent predictor for postoperative recurrence, but postoperative radiation in such patients does not seem to have any survival benefits. 目的: 探讨早期子宫颈神经内分泌癌(NECC)术后放疗的价值,并分析高危病理因素对预后的影响。 方法: 本研究为单中心回顾性队列研究,收集2011年1月至2022年4月中国医学科学院北京协和医院收治的早期(Ⅰ~Ⅱa2期)NECC患者,均行子宫广泛性切除术±辅助治疗,根据术后是否放疗分为术后未放疗组和术后放疗组,对术后复发的相关因素进行单因素及多因素logistic回归分析;采用Kaplan-Meier法计算并比较两组患者的无进展生存(PFS)时间、总生存(OS)时间、复发率和死亡率。 结果: (1)共62例早期NECC患者纳入本研究,其年龄为(43.6±11.7)岁;其中,术后未放疗组33例、术后放疗组29例。(2)术后中位随访时间为37个月(范围:12~116个月),随访期内23例(37%)复发,其中7例(11%)为盆腔内复发、20例(32%)为盆腔外复发[其中4例(6%)盆腔内、外均有复发]。与未放疗组相比,术后放疗组的盆腔内复发率(18%、3%,P=0.074)降低,盆腔外复发率(24%、41%,P=0.150)和总复发率(33%、41%,P=0.513)均升高,但两组分别比较,差异均无统计学意义。单因素分析显示,淋巴脉管间隙浸润、子宫颈间质浸润≥1/2均为显著影响早期NECC患者术后复发的危险因素(P均<0.05);多因素分析显示,淋巴脉管间隙浸润为影响早期NECC患者术后复发的独立危险因素(OR=23.03,95%CI为3.55~149.39,P=0.001)。(3)随访期内18例(29%,18/62)死亡,术后未放疗组10例(30%,10/33)、术后放疗组8例(28%,8/29),两组比较,差异无统计学意义(P=0.814)。62例早期NECC患者的3年生存率为79.2%,5年生存率为60.8%。对不同高危病理因素进行亚组分析显示,与术后未放疗组相比,术后放疗组中子宫颈间质浸润≥1/2所占比例更高(27%、64%;P=0.011),此类患者术后放疗使PFS时间(32.3、53.9个月)和OS时间(39.4、73.4个月)有延长趋势,但分别比较,差异均无统计学意义(P=0.704,P=0.371);有淋巴脉管间隙浸润患者中,与术后未放疗患者相比,术后放疗患者并未改善PFS时间(54.5、37.3个月,P=0.860)和OS时间(56.2、62.4个月,P=0.550)。 结论: 早期NECC手术后放疗有减少盆腔内复发的趋势,但未能降低盆腔外复发率和总复发率,未能改善死亡率;对于子宫颈间质浸润≥1/2的患者,术后放疗有延长PFS时间和OS时间的趋势;淋巴脉管间隙浸润为术后肿瘤复发的独立危险因素,但此类患者术后放疗并无生存获益。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Song XC, Zhang H, Zhong S, et al. [Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix]. Zhonghua Fu Chan Ke Za Zhi. 2023. PMID: 37724385. doi:10.3760/cma.j.cn112141-20230614-00263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。